What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His main research concerns Immunology, Cancer, Antigen, Immunotherapy and Vaccination.
His Immunology research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell and Internal medicine, Clinical trial.
His Clinical trial study incorporates themes from Human leukocyte antigen and Oncology.
His Antigen research incorporates themes from Viral Vaccine and Chickenpox.
The study incorporates disciplines such as Epitope, Prostate cancer and Combination therapy in addition to Immunotherapy.
His studies in Vaccination integrate themes in fields like Cancer vaccine and Lung cancer.
His most cited work include:
- Multifunctional Alloys Obtained via a Dislocation-Free Plastic Deformation Mechanism. (621 citations)
- Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese (431 citations)
- Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. (153 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Internal medicine, Cancer, Vaccination and Oncology.
As part of his studies on Immunology, Akira Yamada often connects relevant areas like Cytotoxic T cell.
In Cytotoxic T cell, Akira Yamada works on issues like Human leukocyte antigen, which are connected to Virology and Hepatitis C virus.
His study focuses on the intersection of Vaccination and fields such as Adverse effect with connections in the field of Randomized controlled trial.
His Antigen research includes themes of Molecular biology, Antibody and Adenocarcinoma.
The concepts of his Immunotherapy study are interwoven with issues in Peripheral blood mononuclear cell and Combination therapy.
He most often published in these fields:
- Immunology (45.38%)
- Internal medicine (31.73%)
- Cancer (28.51%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (31.73%)
- Oncology (22.89%)
- Vaccination (28.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Vaccination, Cancer and Immunology.
Akira Yamada has researched Internal medicine in several fields, including Gastroenterology and Peptide vaccine.
His Oncology research incorporates elements of Survival analysis, Randomized controlled trial, Prostate cancer and Chemotherapy.
His work carried out in the field of Vaccination brings together such families of science as Adverse effect and Immune system.
His work deals with themes such as Biomarker and Hazard ratio, which intersect with Cancer.
His studies deal with areas such as Colorectal cancer and HMGB1 as well as Immunology.
Between 2014 and 2021, his most popular works were:
- A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer (50 citations)
- A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer (43 citations)
- An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Akira Yamada mostly deals with Internal medicine, Vaccination, Immunology, Oncology and Immune system.
As part of the same scientific family, he usually focuses on Internal medicine, concentrating on Gastroenterology and intersecting with Hazard ratio.
His Vaccination research is multidisciplinary, relying on both Cancer vaccine, Adverse effect, Antigen and Peptide vaccine.
Akira Yamada has included themes like Cancer, Immunotherapy, Hepatitis C and Hepatitis C virus in his Antigen study.
His study looks at the relationship between Immunology and fields such as Survival analysis, as well as how they intersect with chemical problems.
His Oncology study integrates concerns from other disciplines, such as Survival rate, Randomized controlled trial and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
